baseclick working towards mRNA therapeutic development utilizing the Nobel Prize awarded “Click Chemistry” bioconjugation technology
baseclick has adapted the “Click Chemistry” bioconjugation method for many applications in nucleic acid modification –including the modification of oligomeric nucleic acids such as DNA, RNA oligos as well as mRNA. In 2022, Prof. Dr. Carolyn R. Bertozzi, Prof. Dr. Morten Meldal and Prof. Dr. K. Barry Sharpless, mentor of baseclick’s click chemistry modification technology, were awarded the chemistry Nobel Prize from the Royal Swedish Academy of Sciences, “for the development of click chemistry and biorthogonal chemistry”.

Symbolic image
Computer-generated image
baseclick has started its own COVID-19 mRNA program utilizing its mRNA modification technology to target sugar modified mRNA specifically to immune cells to raise an immune response against the N-protein of SARS-CoV2, obtaining a positive evaluationfrom the Paul Ehrlich Institute.
Dr. Frischmuth, CEO and inventor of the Click Chemistry mRNA modification technology, expressed his satisfaction for the progress made and his hope “to accelerate the development of mRNA as a new therapeutics class.”
Topics
Organizations
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.